Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00392340
Status:
UNKNOWN
Last Update Posted:
2013-09-17
First Post:
2006-10-25
Brief Title:
Topotecan Vincristine and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma
Sponsor:
Childrens Cancer and Leukaemia Group
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000508641
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Childrens Cancer and Leukaemia Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None